DI GIACOMO ANNA MARIA | Professor page

Tini, P., Donnini, F., Marampon, F., Vannini, M., Carfagno, T., Pastina, P., et al. (2025). Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide. BRAIN SCIENCES, 15(7) [10.3390/brainsci15070713]. - view more
Di Giacomo, A.M., Subudhi, S., Vos, W., Andreatta, M., Carmona, S., Mctavish, W., et al. (2025). Perspectives on the role of “-Omics” in predicting response to immunotherapy. EUROPEAN JOURNAL OF CANCER, 220 [10.1016/j.ejca.2025.115393]. - view more
Di Giacomo, A.M., Bartalini, S., D'Alonzo, V., Cerase, A., Cutarella, S., Rossi, G., et al. (2025). Neurological adverse events of ICI therapy: A ten-year comprehensive management from a multidisciplinary team. EUROPEAN JOURNAL OF CANCER, 228 [10.1016/j.ejca.2025.115707]. - view more
Di Giacomo, A.M., Chiarion-Sileni, V., Del Vecchio, M., Ferrucci, P.F., Guida, M., Quaglino, P., et al. (2024). Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial. EUROPEAN JOURNAL OF CANCER, 199 [10.1016/j.ejca.2024.113531]. - view more
Mandala, M., Lorigan, P., Sergi, M.C., Benannoune, N., Serra, P., Vitale, M.G., et al. (2024). Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study. EUROPEAN JOURNAL OF CANCER, 199, 1-7 [10.1016/j.ejca.2024.113542]. - view more